Clinical Trial Update: 18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for 18F-FTC-146 PET/CT in newly diagnosed osteosarcoma; study terminated with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• [18F]-FTC-146 (FTC-146 radiotracer labeled with Fluorine-18)

Snippet

Sponsor: Davidzon, Guido, M.D. | Conditions: Osteosarcoma | Phase 2 | Status: TERMINATED | Results posted: 2023-11-14